Fibrinogen receptor antagonists having substituted...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 211/34 (2006.01) A61K 31/435 (2006.01) A61K 31/495 (2006.01) C07D 211/46 (2006.01) C07D 295/18 (2006.01) C07D 295/185 (2006.01) C07D 401/06 (2006.01) C07D 403/06 (2006.01) C07D 405/06 (2006.01) C07D 405/12 (2006.01) C07D 409/06 (2006.01) C07D 413/06 (2006.01) C07D 417/06 (2006.01)

Patent

CA 2208682

The invention provides compounds of the following general formula (I) and pharmaceutically acceptable salts thereof which can be used for inhibiting platelet aggregation, blood coagulation in extracorporeal circulation or the reocclusion of coronary arteries: Image

L'invention porte sur des composés de formule générale (I) et leurs sels pharmacocompatibles.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Fibrinogen receptor antagonists having substituted... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fibrinogen receptor antagonists having substituted..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibrinogen receptor antagonists having substituted... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1489763

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.